135 related articles for article (PubMed ID: 29296698)
1. Hemoglobin variants identified in the Uganda Sickle Surveillance Study.
Schaefer BA; Kiyaga C; Howard TA; Ndeezi G; Hernandez AG; Ssewanyana I; Paniagua MC; Ndugwa CM; Aceng JR; Ware RE
Blood Adv; 2016 Nov; 1(1):93-100. PubMed ID: 29296698
[TBL] [Abstract][Full Text] [Related]
2. Burden of sickle cell trait and disease in the Uganda Sickle Surveillance Study (US3): a cross-sectional study.
Ndeezi G; Kiyaga C; Hernandez AG; Munube D; Howard TA; Ssewanyana I; Nsungwa J; Kiguli S; Ndugwa CM; Ware RE; Aceng JR
Lancet Glob Health; 2016 Mar; 4(3):e195-200. PubMed ID: 26833239
[TBL] [Abstract][Full Text] [Related]
3. HPLC-ESI-MS/MS analysis of hemoglobin peptides in tryptic digests of dried-blood spot extracts detects HbS, HbC, HbD, HbE, HbO-Arab, and HbG-Philadelphia mutations.
Haynes CA; Guerra SL; Fontana JC; DeJesús VR
Clin Chim Acta; 2013 Sep; 424():191-200. PubMed ID: 23796846
[TBL] [Abstract][Full Text] [Related]
4. Separation of hemoglobin variants with similar charge by capillary isoelectric focusing: value of isoelectric point for identification of common and uncommon hemoglobin variants.
Hempe JM; Craver RD
Electrophoresis; 2000 Mar; 21(4):743-8. PubMed ID: 10733215
[TBL] [Abstract][Full Text] [Related]
5. Compound heterozygosity for Hb S [β6(A3)Glu→Val] and Hb Kenya (Aγ81Leu-β86Ala) in a Ugandan woman.
Han ZJ; Lapuz C; Rovenger JF; Dreyfus PA; Vispo BG; Ou CN; Luo HY; Chui DH; Gallivan MV
Hemoglobin; 2012; 36(3):270-5. PubMed ID: 22384817
[TBL] [Abstract][Full Text] [Related]
6. Modification of hemoglobin H disease by sickle trait.
Matthay KK; Mentzer WC; Dozy AM; Kan YW; Bainton DF
J Clin Invest; 1979 Oct; 64(4):1024-32. PubMed ID: 479366
[TBL] [Abstract][Full Text] [Related]
7. Strategy linking several analytical methods of neonatal screening for sickle cell disease.
Ducrocq R; Pascaud O; Bévier A; Finet C; Benkerrou M; Elion J
J Med Screen; 2001; 8(1):8-14. PubMed ID: 11373853
[TBL] [Abstract][Full Text] [Related]
8. Newborn screening for sickle cell disease using tandem mass spectrometry.
Boemer F; Ketelslegers O; Minon JM; Bours V; Schoos R
Clin Chem; 2008 Dec; 54(12):2036-41. PubMed ID: 18832473
[TBL] [Abstract][Full Text] [Related]
9. Cord blood screening for alpha-thalassemia and hemoglobin variants by isoelectric focusing in northern Thai neonates: correlation with genotypes and hematologic parameters.
Charoenkwan P; Taweephol R; Sirichotiyakul S; Tantiprabha W; Sae-Tung R; Suanta S; Sakdasirisathaporn P; Sanguansermsri T
Blood Cells Mol Dis; 2010 Jun; 45(1):53-7. PubMed ID: 20299254
[TBL] [Abstract][Full Text] [Related]
10. Molecular Detection of Hemoglobin O-Arab in the Sudanese Population.
Elbashir I; Elsayed Yousif TY
Int J Gen Med; 2023; 16():3323-3330. PubMed ID: 37554704
[TBL] [Abstract][Full Text] [Related]
11. Homozygous Hb Stanleyville-II [alpha2 78(EF7) Asn>Lys; HBA2:c.237C>A, not C>G] associated with genotype -α 3.7/-α 3.7 in two Brazilian families.
Pimentel FS; Silva MR; Ferraz MH; Carvalho NO; Perone C; del Castillo DM; Januario JN; Viana MB
Int J Lab Hematol; 2011 Dec; 33(6):566-9. PubMed ID: 21470372
[TBL] [Abstract][Full Text] [Related]
12. Sickle haemoglobin and haemoglobin Stanleyville II: possible confusion with sickle cell-haemoglobin C disease.
Serjeant GR; Wild B; Tebasulwa S; Mason KP; Serjeant BE; Ndugwa CM
East Afr Med J; 2005 Jul; 82(7):367-70. PubMed ID: 16167711
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic applications of newborn screening for α-thalassaemias, haemoglobins E and H disorders using isoelectric focusing on dry blood spots.
Jindatanmanusan P; Riolueang S; Glomglao W; Sukontharangsri Y; Chamnanvanakij S; Torcharus K; Viprakasit V
Ann Clin Biochem; 2014 Mar; 51(Pt 2):237-47. PubMed ID: 23901141
[TBL] [Abstract][Full Text] [Related]
14. Rare hemoglobin variants in Tunisian population.
Zorai A; Moumni I; Mosbahi I; Douzi K; Chaouachi D; Guemira F; Abbes S
Int J Lab Hematol; 2015 Apr; 37(2):148-54. PubMed ID: 24905386
[TBL] [Abstract][Full Text] [Related]
15. Implementation of the newborn screening programme for sickle cell disease in England: results for 2003-2005.
Streetly A; Clarke M; Downing M; Farrar L; Foo Y; Hall K; Kemp H; Newbold J; Walsh P; Yates J; Henthorn J
J Med Screen; 2008; 15(1):9-13. PubMed ID: 18416948
[TBL] [Abstract][Full Text] [Related]
16. Hemoglobin analyses in the Netherlands reveal more than 80 different variants including six novel ones.
van Zwieten R; Veldthuis M; Delzenne B; Berghuis J; Groen J; Ait Ichou F; Clifford E; Harteveld CL; Stroobants AK
Hemoglobin; 2014; 38(1):1-7. PubMed ID: 24200101
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of high performance liquid chromatography (HPLC) pattern and prevalence of beta-thalassaemia trait among sickle cell disease patients in Lagos, Nigeria.
Adeyemo T; Ojewunmi O; Oyetunji A
Pan Afr Med J; 2014; 18():71. PubMed ID: 25400838
[TBL] [Abstract][Full Text] [Related]
18. Innovative PCR without DNA extraction for African sickle cell disease diagnosis.
Detemmerman L; Olivier S; Bours V; Boemer F
Hematology; 2018 Apr; 23(3):181-186. PubMed ID: 28929945
[TBL] [Abstract][Full Text] [Related]
19. First case of Hb Fontainebleau with sickle haemoglobin and other non-deletional α gene variants identified in neonates during newborn screening for sickle cell disorders.
Upadhye DS; Jain D; Nair SB; Nadkarni AH; Ghosh K; Colah RB
J Clin Pathol; 2012 Jul; 65(7):654-9. PubMed ID: 22461654
[TBL] [Abstract][Full Text] [Related]
20. Limitations of Hb F as a phenotypic modifier in sickle cell disease: study of Kuwaiti Arab patients.
Adekile AD
Hemoglobin; 2011; 35(5-6):607-17. PubMed ID: 21999156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
